Molecular Imaging: Page 78

PET/CT predicts survival outcomes in immunotherapy patients

By Will Morton

PET/CT imaging in patients with metastatic melanoma who receive immunotherapy drugs can show which patients are more or less likely to survive, according to a study published December 12 in the European Journal of Radiology.

December 15, 2021

Rosatom to build facility in Serbia

By AuntMinnie.com staff writers

Russia's state nuclear corporation Rosatom has inked a deal to build a new facility for radiopharmaceutical production in Serbia within the next three years.

December 13, 2021

PET links anxiety and risk of cognitive decline

By Will Morton

Clinical anxiety may increase the risk of cognitive decline in people with early signs of Alzheimer's disease on PET scans with the Pittsburgh compound B (PiB) radiotracer, according to research published December 8 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

December 12, 2021

PET/MRI can improve diagnosis of peritoneal cancer

By Will Morton

PET/MRI performs better than standard imaging for diagnosing cancer that has spread to the peritoneum from primary tumors in the abdominal cavity, according to research presented at RSNA 2021 in Chicago.

December 9, 2021

New tracer bests FDG for diagnosing liver cancer

By Will Morton

PET/CT imaging of hepatocellular carcinoma with an experimental gallium-68-based radiotracer is more effective than with FDG, according to research presented at RSNA 2021 in Chicago.

December 9, 2021

AuntMinnie.com Molecular Imaging Insider

By Will Morton

December 7, 2021

RSNA, RadSite partner on FDG PET/CT biomarker profile

By AuntMinnie.com staff writers

The Radiological Society of North America (RSNA) and diagnostic imaging certification firm RadSite have teamed on a new initiative called the RSNA Quantitative Imaging Biomarkers Alliance Profile for fluorodeoxyglucose (FDG) PET/CT imaging.

December 7, 2021

PET diagnoses prosthetic joint infection

By Will Morton

A new carbon-11-based PET radiotracer can help diagnose infection in patients with prosthetic joints, a major step toward a noninvasive method for imaging living bacteria in humans, according to research presented at the RSNA 2021 meeting in Chicago.

December 6, 2021

New PET tracer detects lung tumors

By Will Morton

An experimental PET radiotracer is safe and appears effective for detecting neuroendocrine tumors in patients with newly diagnosed or recurrent small cell lung cancer, according to research presented Thursday at RSNA 2021 in Chicago.

December 3, 2021

ITM, Navigo collaborate on radioisotope

By AuntMinnie.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich and Navigo Proteins are teaming up to develop a fibroblast activation protein-targeted radiopharmaceutical program for the treatment of solid tumors.

December 2, 2021

PET/MRI proves TNF blockers effective for ankylosing spondylitis

By Will Morton

PET/MRI scans of ankylosing spondylitis patients show that tumor necrosis factor (TNF) blockers reduce the cellular bone activity driving the disease, according to research presented Thursday at RSNA 2021 in Chicago.

December 2, 2021

New radiotracer improves management of prostate cancer patients

By Will Morton

PET imaging with the radiotracer F-18 DCFPyL detects more metastatic tumors and can significantly improve treatment decisions compared with conventional imaging in patients with prostate cancer, according to research presented Wednesday at RSNA 2021 in Chicago.

December 1, 2021

Previous Page

Page 78 of 611

Next Page